<DOC>
	<DOCNO>NCT02392234</DOCNO>
	<brief_summary>The purpose study evaluate efficacy VX-661 combination ivacaftor ivacaftor monotherapy subject Cystic Fibrosis ( CF ) .</brief_summary>
	<brief_title>A Phase 3 Study Evaluate Efficacy Safety Ivacaftor VX-661 Combination With Ivacaftor Subjects Aged 12 Years Older With Cystic Fibrosis , Heterozygous F508del-CFTR Mutation</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Heterozygous F508delCFTR second allele CFTR mutation predict residual function Forced Expiratory Volume 1 Second ( FEV1 ) great equal ( ≥ ) 40 percent ( % ) less equal ( ≤ ) 90 % predict normal age , sex , height screen . Sweat chloride value ≥60 millimole per liter ( mmol/L ) test result obtain screen OR document subject 's medical record . Sweat chloride value le ( &lt; ) 60 mmol/L must document evidence chronic sinopulmonary disease Stable CF disease judge investigator History comorbidity , opinion investigator , might confound result study pose additional risk administer study drug subject . An acute upper low respiratory infection , pulmonary exacerbation , change therapy ( include antibiotic ) pulmonary disease within 28 day Day 1 A 12lead electrocardiogram ( ECG ) demonstrate correct QT interval ( QTc ) great ( &gt; ) 450 millisecond ( msec ) Screening Visit History solid organ hematological transplantation History evidence cataract , lens opacity , Ysuture , lamellar ring determine clinically significant ophthalmologist ophthalmologic examination Screening Period Ongoing prior participation investigational drug study ( include study investigate VX661 , lumacaftor [ VX809 ] , and/or ivacaftor ) within 30 day screen Use restrict medication food within specify window first dose study drug Pregnant nursing female ( female childbearing potential must negative pregnancy test Screening Day 1 ) . Sexually active subject reproductive potential willing follow contraception requirement Colonization organisms associate rapid decline pulmonary status</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>